These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
72 related articles for article (PubMed ID: 3314023)
1. Skin transplantation in rats and monkeys: evaluation of efficient treatment with 15-deoxyspergualin. Dickneite G; Schorlemmer HU; Weinmann E; Bartlett RR; Sedlacek HH Transplant Proc; 1987 Oct; 19(5):4244-7. PubMed ID: 3314023 [No Abstract] [Full Text] [Related]
2. Administration schedule of 15-deoxyspergualin and combination therapy with cyclosporin A in rat tail skin transplantation. Dickneite G; Schorlemmer HU; Racenberg J; Sedlacek HH Transplant Proc; 1989 Feb; 21(1 Pt 1):1097-8. PubMed ID: 2650069 [No Abstract] [Full Text] [Related]
3. Comparison of the new immunosuppressive agent 15-deoxyspergualin and cyclosporine A after highly allogeneic pancreas transplantation. Schubert G; Stoffregen C; Timmermann W; Schang T; Thiede A Transplant Proc; 1987 Oct; 19(5):3978-9. PubMed ID: 3313974 [No Abstract] [Full Text] [Related]
4. Effect of 15-deoxyspergualin on experimental organ transplantation. Todo S; Murase N; Kahn D; Pan CE; Okuda K; Cemej S; Casavilla A; Mazzaferro V; Ghalab A; Rhoe BS Transplant Proc; 1988 Feb; 20(1 Suppl 1):233-6. PubMed ID: 3279614 [TBL] [Abstract][Full Text] [Related]
5. Prolongation of graft survival in allogeneic limb transplantation by 15-deoxyspergualin. Walter P; Menger MD; Thies J; Wolf B; Dickneite G Transplant Proc; 1989 Feb; 21(1 Pt 3):3186. PubMed ID: 2650449 [No Abstract] [Full Text] [Related]
6. Effect of short-term administration of deoxyspergualin in rat allogeneic renal transplantation. Chikaraishi T; Seki T; Takeuchi I; Tanda K; Kanagawa K; Togashi M; Koyanagi T Transplant Proc; 1992 Aug; 24(4):1631-2. PubMed ID: 1496679 [No Abstract] [Full Text] [Related]
7. Synergistic effect of 15-deoxyspergualin and cyclosporin A in pancreatic transplantation. Schubert G; Stoffregen C; Loske G; Timmermann W; Schang T; Thiede A Transplant Proc; 1989 Feb; 21(1 Pt 1):1096. PubMed ID: 2495590 [No Abstract] [Full Text] [Related]
8. The immunosuppressive agent 15-deoxyspergualin induces tolerance and modulates MHC-antigen expression and interleukin-1 production in the early phase of rat allograft responses. Waaga AM; Ulrichs K; Krzymanski M; Treumer J; Hansmann ML; Rommel T; Müller-Ruchholtz W Transplant Proc; 1990 Aug; 22(4):1613-4. PubMed ID: 2389421 [No Abstract] [Full Text] [Related]
9. Transplantation tolerance after short-term administration of 15-deoxyspergualin in orthotopic rat liver transplantation. Engemann R; Gassel HJ; Lafrenz E; Stoffregen C; Thiede A Transplant Proc; 1987 Oct; 19(5):4241-3. PubMed ID: 3314022 [No Abstract] [Full Text] [Related]
10. Suppression of macrophage function and prolongation of graft survival by the new guanidinic-like structure, 15-deoxyspergualin. Dickneite G; Schorlemmer HU; Sedlacek HH; Falk W; Ulrichs K; Müller-Ruchholtz W Transplant Proc; 1987 Feb; 19(1 Pt 2):1301-4. PubMed ID: 3547862 [No Abstract] [Full Text] [Related]
11. Treatment of acute rejection episodes and induction of tolerance in rat skin allotransplantation by 15-deoxyspergualin. Schorlemmer HU; Dickneite G; Seiler FR Transplant Proc; 1990 Aug; 22(4):1626-30. PubMed ID: 2389427 [No Abstract] [Full Text] [Related]
12. Prolongation of allograft and xenograft survival with 15-deoxyspergualin. Corry RJ; Cutkomp J; Oberholser JH; Kapelanski DP; Wakely E Transplant Proc; 1989 Feb; 21(1 Pt 1):530-1. PubMed ID: 2650192 [No Abstract] [Full Text] [Related]
13. Synergistic effects of 15-deoxyspergualin with cyclosporine and the TCR-targeted monoclonal antibody R73 to induce specific unresponsiveness to skin allografts in rats. Schorlemmer HU; Dickneite G; Kurrle R; Seiler FR Transplant Proc; 1995 Feb; 27(1):414-6. PubMed ID: 7879044 [No Abstract] [Full Text] [Related]
14. Prophylactic use of deoxyspergualin in living related renal transplantation. Okazaki H; Sato T; Jimbo M; Senga S; Amada N; Oguma S Transplant Proc; 1991 Feb; 23(1 Pt 2):1094-5. PubMed ID: 1989157 [No Abstract] [Full Text] [Related]
15. Prolongation of islet and pancreas graft survival in spontaneous diabetic BB/W rats by perioperative cyclosporin or 15-deoxyspergualin therapy. von Specht BU; Dibelius A; Königsberger H; Lodde G; Roth H; Permanetter W Transplant Proc; 1989 Feb; 21(1 Pt 1):965-7. PubMed ID: 2495636 [No Abstract] [Full Text] [Related]
16. Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation. Inagaki K; Fukuda Y; Sumimoto K; Matsuno K; Ito H; Takahashi M; Dohi K Transplant Proc; 1989 Feb; 21(1 Pt 1):1069-71. PubMed ID: 2468210 [No Abstract] [Full Text] [Related]
17. Cardiac xenograft survival in baboons treated with cyclosporine in combination with conventional immunosuppression. Sadeghi AM; Robbins RC; Smith CR; Kurlansky RA; Michler RE; Reemtsma K; Rose EA Transplant Proc; 1987 Feb; 19(1 Pt 2):1149-52. PubMed ID: 3547854 [No Abstract] [Full Text] [Related]
18. Synergistic effect of 15-deoxyspergualin and cyclosporine in prolonging survival of rat cardiac allografts. Kaji H; Chou DT; Sutherland DE; Stephanian E; Gores PF Transplant Proc; 1994 Apr; 26(2):869-70. PubMed ID: 8171689 [No Abstract] [Full Text] [Related]
19. Comparative studies on the immunosuppressive activity of FK506, 15-deoxyspergualin, and cyclosporine. Ochiai T; Nakajima K; Sakamoto K; Nagata M; Gunji Y; Asano T; Isono K; Sakamaki T; Hamaguchi K Transplant Proc; 1989 Feb; 21(1 Pt 1):829-32. PubMed ID: 2468228 [No Abstract] [Full Text] [Related]
20. Blastogenic responses and the release of interleukins 1 and 2 by spleen cells obtained from rat skin allograft recipients administered with 15-deoxyspergualin. Nemoto K; Abe F; Nakamura T; Ishizuka M; Takeuchi T; Umezawa H J Antibiot (Tokyo); 1987 Jul; 40(7):1062-4. PubMed ID: 3305455 [No Abstract] [Full Text] [Related] [Next] [New Search]